Cargando…
Erythropoietin and Its Angiogenic Activity
Erythropoietin (EPO) is the main hematopoietic hormone acting on progenitor red blood cells via stimulation of cell growth, differentiation, and anti-apoptosis. However, its receptor (EPOR) is also expressed in various non-hematopoietic tissues, including endothelium. EPO is a pleiotropic growth fac...
Autores principales: | Kimáková, Patrícia, Solár, Peter, Solárová, Zuzana, Komel, Radovan, Debeljak, Nataša |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536009/ https://www.ncbi.nlm.nih.gov/pubmed/28703764 http://dx.doi.org/10.3390/ijms18071519 |
Ejemplares similares
-
The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021) -
STAT5 as a Key Protein of Erythropoietin Signalization
por: Tóthová, Zuzana, et al.
Publicado: (2021) -
Recombinant human erythropoietin alters gene expression and stimulates proliferation of MCF-7 breast cancer cells
por: Trost, Nina, et al.
Publicado: (2013) -
Methylation of the first exon in the erythropoietin receptor gene does not correlate with its mRNA and protein level in cancer cells
por: Fecková, Barbora, et al.
Publicado: (2019) -
Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)